Joyce So

Joyce So

Auto-generated profile, based on publicly available information

Joyce So

Fred A. Litwin Family Centre in Genetic Medicine, University Health Network and Mount Sinai Hospital, 60 Murray Street, Box 34, 3rd Floor, Room 400, Toronto, ON, M5T 3L9, Canada.

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2014 in Journal of Neurodevelopmental Disorders
Verified
Journal Article
Open access
PDF file
SCSébastien Chénier
Sébastien Chénier
GYGrace Yoon
Grace Yoon
BABob Argiropoulos
Bob Argiropoulos
JLJulie Lauzon
Julie Lauzon
RLRachel Laframboise
Rachel Laframboise
DSDimitri J Stavropoulos
Dimitri J Stavropoulos
The chromodomain helicase DNA binding domain (CHD) proteins modulate gene expression via their ability to remodel chromatin structure and influence histone acetylation. Recent studies have shown that CHD2 protein plays a critical role in embryonic development, tumor suppression and survival. Like other genes encoding members of the CHD family, pathogenic mutations in the CHD2 gene are expected to be implicated in human disease. In fact, there is emerging evidence suggesting that CHD2 might contribute to a broad spectrum of neurodevelopmental disorders. Despite growing evidence, a description of the full phenotypic spectrum of this condition is lacking. We conducted a multicentre study to identify and characterise the clinical features associated with haploinsufficiency of CHD2. Patients with deletions of this gene were identified from among broadly ascertained clinical cohorts undergoing genomic microarray analysis for developmental delay, congenital anomalies and/or autism spectrum disorder. Detailed clinical assessments by clinical geneticists showed recurrent clinical symptoms, including developmental delay, intellectual disability, epilepsy, behavioural problems and autism-like features without characteristic facial gestalt or brain malformations observed on magnetic resonance imaging scans. Parental analysis showed that the deletions affecting CHD2 were de novo in all four patients, and analysis of high-resolution microarray data derived from 26,826 unaffected controls showed no deletions of this gene. The results of this study, in addition to our review of the literature, support a causative role of CHD2 haploinsufficiency in developmental delay, intellectual disability, epilepsy and behavioural problems, with phenotypic variability between individuals.

3 October 2015 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SHSamantha Aliza Hershenfeld
Samantha Aliza Hershenfeld
SWSyed Wasim
Syed Wasim
VMVanda McNiven
Vanda McNiven
MPManasi Parikh
Manasi Parikh
PMPaula Majewski
Paula Majewski
JSJoyce So
Joyce So


3 May 2016 in Human Genetics
Verified
Journal Article
Closed access
PDF file
PSPierre Sinajon
Pierre Sinajon
DVDeborah Verbaan
Deborah Verbaan
JSJoyce So
Joyce So

25 June 2015 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
MRMuhammad Arshad Rafiq
Muhammad Arshad Rafiq
CLClaire S Leblond
Claire S Leblond
ASArif Nadeem Saqib
Arif Nadeem Saqib
AVAkshita K. Vincent
Akshita K. Vincent
AAAmirthagowri Ambalavanan
Amirthagowri Ambalavanan
LXLan Xiong
Lan Xiong
Cohen Syndrome (COH1) is a rare autosomal recessive disorder, principally identified by ocular, neural and muscular deficits. We identified three large consanguineous Pakistani families with intellectual disability and in some cases with autistic traits. Clinical assessments were performed in order to allow comparison of clinical features with other VPS13B mutations. Homozygosity mapping followed by whole exome sequencing and Sanger sequencing strategies were used to identify disease-related mutations. We identified two novel homozygous deletion mutations in VPS13B, firstly a 1 bp deletion, NM_017890.4:c.6879delT; p.Phe2293Leufs*24, and secondly a deletion of exons 37-40, which co-segregate with affected status. In addition to COH1-related traits, autistic features were reported in a number of family members, contrasting with the “friendly” demeanour often associated with COH1. The c.6879delT mutation is present in two families from different regions of the country, but both from the Baloch sub-ethnic group, and with a shared haplotype, indicating a founder effect among the Baloch population. We suspect that the c.6879delT mutation may be a common cause of COH1 and similar phenotypes among the Baloch population. Additionally, most of the individuals with the c.6879delT mutation in these two families also present with autistic like traits, and suggests that this variant may lead to a distinct autistic-like COH1 subgroup.

5 December 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
JSJoyce So
Joyce So
TSTracy Stockley
Tracy Stockley
DSDimitri J. Stavropoulos
Dimitri J. Stavropoulos